Filter
570
Filtered Results: 570
Text search:
MERS
Featured
Recommendations
87
New Publications
60
Language
Document type
Guidelines
218
Studies & Reports
93
No document type
92
Fact sheets
58
Manuals
39
Training Material
23
Strategic & Response Plan
23
Online Courses
12
Resource Platforms
4
Infographics
3
Brochures
2
Situation Updates
2
Videos
1
Countries / Regions
Brazil
28
Russia
26
Germany
20
Latin America and the Carribbean
20
Global
19
India
16
Mozambique
12
South Africa
11
Angola
11
Syria
10
Eastern Europe and Central Asia
10
Western and Central Europe
10
West and Central Africa
9
Middle East and North Africa
9
Ethiopia
8
Africa
8
Vietnam
8
Indonesia
7
Peru
7
East and Southern Africa
7
Italy
7
Spain
7
Guinea-Bissau
6
Turkey
6
Kenya
6
Sierra Leone
5
Ecuador
5
South–East Asia Region
5
Paraguay
5
Philippines
4
China
4
Bangladesh
4
Yemen
4
Eastern Europe
4
Portugal
4
Guinea
3
Liberia
3
Thailand
3
Ukraine
3
Bolivia
3
France
3
Haiti
2
Cambodia
2
Rwanda
2
Malawi
2
Colombia
2
El Salvador
2
Chile
2
Western Pacific Region
2
Asia
2
Laos
2
Nigeria
1
Senegal
1
Saudi Arabia
1
Cameroon
1
Ghana
1
Niger
1
Zimbabwe
1
South Sudan
1
Afghanistan
1
Chad
1
Malaysia
1
Ireland
1
Serbia
1
Honduras
1
Guatemala
1
Madagascar
1
Myanmar / Burma
1
Sri Lanka
1
Venezuela
1
Estonia
1
Iran
1
Mauritius
1
United Kingdom
1
Authors & Publishers
Publication Years
Category
Countries
219
Key Resources
26
Clinical Guidelines
22
Public Health
20
Women & Child Health
19
Pharmacy & Technologies
16
Capacity Building
8
Annual Report MEDBOX
1
Toolboxes
COVID-19
340
Rapid Response
34
Mental Health
24
Planetary Health
23
Global Health Education
15
Disability
13
Ebola
12
Conflict
10
AMR
9
Zika
8
NTDs
8
Refugee
7
HIV
7
TB
6
Pharmacy
6
Health Financing Toolbox
6
Caregiver
5
Social Ethics
3
NCDs
2
Polio
1
Natural Hazards
1
Specific Hazards
1
Interim guidance, 6 October 2021
Direct detection of SARS-CoV-2 viral proteins (antigens) in nasal swabs and other respiratory secretions using lateral flow immunoassays (also known as rapid diagnostic tests, RDTs) offers a faster and less expensive method to test for SARS-CoV-2 than the reference ...
Non-pharmaceutical interventions (NPI) are public health measures that aim to prevent and/or control SARS-CoV-2 transmission in the community. As long as there is no effective and safe vaccine to protect those at risk of severe COVID-19, NPI are the most effective public health interventions against...
AGOSTO – DICIEMBRE 2020
La evolución de la pandemia COVID-19 desde el mes de marzo que se reportó el primer caso ha impactado muy fuertemente al sistema de salud pública y privada del país debido principalmente al número de casos y personas fallecidas.
There is no secret to our procedure: the daily scanning of the literature helps us to stay afloat in the never-ending waves of new publications about SARS-CoV-2 and COVID-19. Many papers discussed in the Top 10 will eventually make it into subsequent editions of COVID Reference.
Prevention, identification and management of health worker infection in the context of COVID-19
recommended
This document provides interim guidance on the prevention, identification and management of health worker infection in the context of COVID-19. It is intended for occupational health departments, infection prevention and control departments or focal points, health facility administrators and public ...
WHO Guidance for Climate Resilient and Environmentally Sustainable Health Care Facilities
recommended
The aim of this guidance is to enhance the capacity of health care facilities to protect and improve the health of their target communities in an unstable and changing climate; and to empower health care facilities to be environmentally sustainable, by optimizing the use of resources and minimizing ...
DESENHO DESTE FORMULÁRIO DE NOTIFICAÇÃO DE CASO (CRF). Este CRF inclui 3 módulos: Módulo 1: deve ser preenchido no primeiro dia de internação na unidade de saúde. Módulo 2: deve ser preenchido diariamente durante a internação hospitalar e pelo número de dias que os recursos permitirem. C...
The COVID-19 pandemic’s immediate costs, measured in lives lost and damaged, have been appalling and continue to rise. In addition, its effects on individuals’ livelihoods and economies around the world have been deep and are likely to be long lasting. While saving lives was the near-exclusive f...
This document draws on scientific evidence from the COVID-19 pandemic and from prior public health research on behaviour change, with the purpose of empowering African Union Member States to promote widespread adoption of masks in the general population. This document complements existing Africa CDC...
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV‑2) causing coronavirus disease 2019 (COVID-19) has reached pandemic levels;
Patients with cardiovascular (CV) risk factors and established cardiovascular disease (CVD) represent a vulnerable population when suffering from COVID-19;
Patien...
Measuring progress towards universal health coverage.
This sixth edition of Health at a Glance Asia/Pacific presents a set of key indicators of health status, the determinants of health, health care resources and utilisation, health care expenditure and financing and quality of care across 27 Asia-...
State of Health in the EU Cycle.
With the coronavirus (COVID-19) once again spreading rapidly, and the re-introduction of containment measures to flatten the curve of the epidemic, it is crucial for policymakers to plan effective strategies to re-open their economies to avoid further re-confinement...
10 December 2020
8 January 2021
Sequencing enabled the world to rapidly identify SARS-CoV-2 and develop diagnostic tests and other tools for outbreak management. Continued genome sequencing supports the monitoring of the disease’s spread and evolution of the virus. Accelerated integration of genome sequencing int...
The growing understanding of how sequence information can contribute to improved public health is driving global investments in sequencing facilities and programmes. The falling cost and complexity of generating GSD provides opportunities for expanding sequencing capacity; however, challenges to wid...
ESTA NOTA INFORMATIVA SUBSTITUI A NOTA INFORMATIVA Nº 11/2020-SE/GAB/SE/MS, DE 15 DE JUNHO DE 2020, QUE SUBSTITUIU A NOTA INFORMATIVANº 9/2020-SE/GAB/SE/MS, DE 20 DE MAIO DE 2020
22 December 2020
The COVID-19 vaccine safety guidance manual has been developed upon recommendation and guidance of GACVS members, as well as by experts incorporating current and available information critical to all stakeholders when COVID-19 vaccines will be introduced.
For ease of use, the man...
Updated 28 December 2020
Version 02, veröffentlicht am 23.12.2020
28 Dec 2020. The main objective of these guidelines is to provide tools for staff working in the field of immunization to support effective communication between health personnel and the general population, with the aim of strengthening, maintaining or recovering trust in vaccines and the immunizati...
